Literature DB >> 24743215

Familial colorectal cancer type X: genetic profiles and phenotypic features.

Mev Dominguez-Valentin1, Christina Therkildsen2, Sabrina Da Silva3, Mef Nilbert1.   

Abstract

Heredity is a major cause of colorectal cancer, but although several rare high-risk syndromes have been linked to disease-predisposing mutations, the genetic mechanisms are undetermined in the majority of families suspected of hereditary cancer. We review the clinical presentation, histopathologic features, and the genetic and epigenetic profiles of the familial colorectal cancer type X (FCCTX) syndrome with the aim to delineate tumor characteristics that may contribute to refined diagnostics and optimized tumor prevention.

Entities:  

Mesh:

Year:  2014        PMID: 24743215     DOI: 10.1038/modpathol.2014.49

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  81 in total

1.  Familial colorectal cancer risk: ESMO Clinical Practice Guidelines.

Authors:  J Balmaña; A Castells; A Cervantes
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.

Authors:  A Middeldorp; R van Eijk; J Oosting; G I Forte; M van Puijenbroek; M van Nieuwenhuizen; W E Corver; D Ruano; T Caldes; J Wijnen; H Morreau; T van Wezel
Journal:  Int J Cancer       Date:  2011-07-15       Impact factor: 7.396

3.  Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations.

Authors:  Wael M Abdel-Rahman; Miina Ollikainen; Reetta Kariola; Heikki J Järvinen; Jukka-Pekka Mecklin; Minna Nyström-Lahti; Sakari Knuutila; Päivi Peltomäki
Journal:  Oncogene       Date:  2005-02-24       Impact factor: 9.867

4.  Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.

Authors:  Anna Abulí; Xavier Bessa; Juan Ramón González; Clara Ruiz-Ponte; Alejandro Cáceres; Jenifer Muñoz; Victoria Gonzalo; Francesc Balaguer; Ceres Fernández-Rozadilla; Dolors González; Luisa de Castro; Juan Clofent; Luís Bujanda; Joaquín Cubiella; Josep M A Reñé; Juan Diego Morillas; Angel Lanas; Joaquim Rigau; Ana M A García; Mercedes Latorre; Joan Saló; Fernando Fernández Bañares; Lídia Argüello; Elena Peña; Angels Vilella; Sabino Riestra; Ramiro Carreño; Artemio Paya; Cristina Alenda; Rosa M Xicola; Brian J Doyle; Rodrigo Jover; Xavier Llor; Angel Carracedo; Antoni Castells; Sergi Castellví-Bel; Montserrat Andreu
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

5.  Risk of cancer in cases of suspected lynch syndrome without germline mutation.

Authors:  María Rodríguez-Soler; Lucía Pérez-Carbonell; Carla Guarinos; Pedro Zapater; Adela Castillejo; Victor M Barberá; Miriam Juárez; Xavier Bessa; Rosa M Xicola; Juan Clofent; Luis Bujanda; Francesc Balaguer; Josep-Maria Reñé; Luisa de-Castro; José C Marín-Gabriel; Angel Lanas; Joaquín Cubiella; David Nicolás-Pérez; Alejandro Brea-Fernández; Sergi Castellví-Bel; Cristina Alenda; Clara Ruiz-Ponte; Angel Carracedo; Antoni Castells; Montserrat Andreu; Xavier Llor; José L Soto; Artemio Payá; Rodrigo Jover
Journal:  Gastroenterology       Date:  2013-01-24       Impact factor: 22.682

6.  LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Authors:  Shuji Ogino; Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Charles S Fuchs
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

7.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Authors:  Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew R Ruszkiewicz; Aaron F Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

8.  Epigenetic signatures of familial cancer are characteristic of tumor type and family category.

Authors:  Emmi I Joensuu; Wael M Abdel-Rahman; Miina Ollikainen; Salla Ruosaari; Sakari Knuutila; Päivi Peltomäki
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

9.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

10.  Epigenetics and colorectal cancer pathogenesis.

Authors:  Kankana Bardhan; Kebin Liu
Journal:  Cancers (Basel)       Date:  2013-06-05       Impact factor: 6.639

View more
  13 in total

1.  Colorectal Cancer in the Adolescent and Young Adult Population.

Authors:  Y Nancy You; Lucas D Lee; Benjamin W Deschner; David Shibata
Journal:  JCO Oncol Pract       Date:  2020-01

Review 2.  Update on Lynch syndrome genomics.

Authors:  Päivi Peltomäki
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

3.  Familial Associations of Colorectal Cancer with Other Cancers.

Authors:  Hongyao Yu; Akseli Hemminki; Kristina Sundquist; Kari Hemminki
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

4.  DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer.

Authors:  Chung-Hsing Chen; Shih Sheng Jiang; Ling-Ling Hsieh; Reiping Tang; Chao A Hsiung; Hui-Ju Tsai; I-Shou Chang
Journal:  Clin Transl Gastroenterol       Date:  2016-12-15       Impact factor: 4.488

5.  Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X.

Authors:  Stefan Haraldsson; Louise Klarskov; Mef Nilbert; Inge Bernstein; Jesper Bonde; Susanne Holck
Journal:  BMC Clin Pathol       Date:  2017-08-17

6.  Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse.

Authors:  Salem Werdyani; Yajun Yu; Georgia Skardasi; Jingxiong Xu; Konstantin Shestopaloff; Wei Xu; Elizabeth Dicks; Jane Green; Patrick Parfrey; Yildiz E Yilmaz; Sevtap Savas
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

7.  Immunoprofiles of colorectal cancer from Lynch syndrome.

Authors:  Joanna Walkowska; Thomas Kallemose; Göran Jönsson; Mats Jönsson; Ove Andersen; Mads Hald Andersen; Inge Marie Svane; Anne Langkilde; Mef Nilbert; Christina Therkildsen
Journal:  Oncoimmunology       Date:  2018-09-26       Impact factor: 8.110

8.  Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.

Authors:  Eduard Schulz; Petra Klampfl; Stefanie Holzapfel; Andreas R Janecke; Peter Ulz; Wilfried Renner; Karl Kashofer; Satoshi Nojima; Anita Leitner; Armin Zebisch; Albert Wölfler; Sybille Hofer; Armin Gerger; Sigurd Lax; Christine Beham-Schmid; Verena Steinke; Ellen Heitzer; Jochen B Geigl; Christian Windpassinger; Gerald Hoefler; Michael R Speicher; C Richard Boland; Atsushi Kumanogoh; Heinz Sill
Journal:  Nat Commun       Date:  2014-10-13       Impact factor: 14.919

9.  Identification of genetic variants for clinical management of familial colorectal tumors.

Authors:  Mev Dominguez-Valentin; Sigve Nakken; Hélène Tubeuf; Daniel Vodak; Per Olaf Ekstrøm; Anke M Nissen; Monika Morak; Elke Holinski-Feder; Alexandra Martins; Pål Møller; Eivind Hovig
Journal:  BMC Med Genet       Date:  2018-02-20       Impact factor: 2.103

10.  Familial Colorectal Cancer Type X in Central Iran: A New Clinicopathologic Description.

Authors:  Mehrdad Zeinalian; Mahdi Hadian; Morteza Hashemzadeh-Chaleshtori; Rasoul Salehi; Mohammad Hassan Emami
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.